125+ Pre-registered delegates (partial list):
VP, Sales & Marketing
Advanced Chemistry Dev Inc.
Director, Global Strategy & Management
AstraZeneca Pharmaceuticals Inc.
Principal Scientist II
Atrium Research & Consulting
Bayer HealthCare AG
President & CTO
Editor in Chief
Biotechnology Industry Organization
Director, Diagnostics & Personalized Medicine Policy
Lead Architect IT & Head
Founder and Chairman
Canterbury District Heath Board
Catholic Health Initiatives
National Director, Center of Tranlational Research
Cedars Sinai Medical Center
Director, Medical Operations
Sr. Application Scientist
Director, Precision Medicine
City of Hope National Medical Center
Director, Research Informatics
Collaborative Drug Discovery Inc.
CEO & President
College of American Pathologists
Director, Personalized Healthcare Initiatives
Cycle Computing LLC
Eli Lilly & Co.
Computational Medicinal Chemist
Manager, Research Chemistry Systems
ExxonMobil Research & Engineering Co.
Sr. Research Associate, Computing
Director, Scientific Affairs
Feinstein Kean Healthcare
Flagship Biosciences LLC
Sr. Scientific Investigator, Computational Biology
H. Lee Moffitt Cancer Center & Research Institute
President & CEO
Harvard Medical School
Research Associate, Biomedical Informatics
Heriot Watt University
Professor, Exercise Biology
IBM TJ Watson Research Center
Post Doctoral Researcher, Functional Genomics & Systems Biology
VP, Translational Medicine
VP, Corporate Development
Analytical Method Development Manager
Institute for Systems Biology
IO Informatics Inc.
Director, Business Development
Director, Translational Bioinformatics
Janssen Pharmaceuticals Inc.
Johns Hopkins University
Research Associate, Clinical Immunology
Johnson & Johnson Pharmaceutical R&D
Manager, Diagnostics and Reagents Business
Kyowa Hakko Kirin Co. Ltd.
Sr. Scientist, Antibody Research Labs
Sr. Scientist, Bioinformatics
LABVANTAGE Solutions Inc.
Account Manager, Life Sciences Biobanking
Project Leader, Software Development
Sr. Director, North American Sales
MD Anderson Cancer Center
Scientific Applications Specialist
Merck & Co.
Executive Director, Project & Pipeline Management
Merck Research Labs
Director of Cheminformatics
PostDoc Research Fellow, Genetics
Swiss Institute of Bioinformatics
Chairman & Co Founder
TeselaGen Biotechnology Inc.
VP, Disruptive Innovation IP & Science
University of The Health Sciences
As part of the Molecular Med TRI-CON 2013, attendees have access to 5 symposia, 18 short courses, and 20 core programs around 5 scientific channels: diagnostics, therapeutics, clinical, informatics, and cancer. The event attracts than 3,000 attendees and provides attendees an opportunity to interact with each other in the shared exhibit/poster hall, plenary keynotes and social functions.
Advance registration discounts are available until January 18, 2013. To learn more and to register, please visit http://www.TriConference.com/
To inquire about sponsoring and/or exhibiting, contact Jon Stroup, 781-972-5483, firstname.lastname@example.org.
Writers and editors are encouraged to attend. To request a press pass, contact Lisa Scimemi email@example.com.
About Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI) (www.healthtech.com)
Cambridge Healthtech Institute